Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs) - He, Qingjian; Lin, Junling; Mo, Chanjuan; Li, Guodong; Lu, Jianzhong; Sun, Qiyin; Cao, Lijun; Gan, Haojian; Sun, Quan; Yao, Jiafang; Lian, Shengyi; Wang, WenJuan (Frontiers in Pharmacology, 2025)